AAAAAA
Results: 1-25/1072
Authors:
BECHTEL P
ALVAN G
Citation: P. Bechtel et G. Alvan, THE PROGRESS OF COST B1 - A EUROPEAN COLLABORATION ON THE STUDY OF INTERINDIVIDUAL DIFFERENCES IN DRUG DISPOSITION AND ACTION, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 585-587
Authors:
ERNST E
RAND JI
BARNES J
STEVINSON C
Citation: E. Ernst et al., ADVERSE-EFFECTS PROFILE OF THE HERBAL ANTIDEPRESSANT ST.-JOHNS-WORT (HYPERICUM-PERFORATUM L.), European Journal of Clinical Pharmacology, 54(8), 1998, pp. 589-594
Authors:
LERNFELT B
LANDAHL S
JOHANSSON P
SELIGMAN L
ABERG J
Citation: B. Lernfelt et al., HEMODYNAMIC AND RENAL EFFECTS OF FELODIPINE IN YOUNG AND ELDERLY SUBJECTS, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 595-601
Authors:
LEONHARDT W
LANGE M
Citation: W. Leonhardt et M. Lange, ANTIOXIDATIVE ACTION OF THE NOVEL CALCIUM-CHANNEL ANTAGONIST MIBEFRADIL ON LOW-DENSITY LIPOPROTEINS, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 603-607
Authors:
MCELNAY JC
ALFURAIH TA
HUGHES CM
SCOTT MG
ELBORN JS
NICHOLLS DP
Citation: Jc. Mcelnay et al., BUCCAL ABSORPTION OF ENALAPRIL AND LISINOPRIL, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 609-614
Authors:
WEIDEKAMM E
RUSING G
CAPLAIN H
SORGEL F
CREVOISIER C
Citation: E. Weidekamm et al., LACK OF BIOEQUIVALENCE OF A GENERIC MEFLOQUINE TABLET WITH THE STANDARD PRODUCT, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 615-619
Authors:
BAUER LA
BLACK DJ
LILL JS
Citation: La. Bauer et al., VANCOMYCIN DOSING IN MORBIDLY OBESE PATIENTS, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 621-625
Authors:
AVONTUUR JAM
BUIJK SLCE
BRUINING HA
Citation: Jam. Avontuur et al., DISTRIBUTION AND METABOLISM OF N-G-NITRO-L-ARGININE METHYL-ESTER IN PATIENTS WITH SEPTIC SHOCK, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 627-631
Authors:
KAMBERI M
KOTEGAWA T
TSUTSUMI K
NAKAMURA K
NAKANO S
Citation: M. Kamberi et al., SPARFLOXACIN PHARMACOKINETICS IN HEALTHY-VOLUNTEERS - THE INFLUENCE OF ACIDIFICATION AND ALKALINIZATION, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 633-637
Authors:
LUCAS RA
GILFILLAN DJ
BERGSTROM RF
Citation: Ra. Lucas et al., A PHARMACOKINETIC INTERACTION BETWEEN CARBAMAZEPINE AND OLANZAPINE - OBSERVATIONS ON POSSIBLE MECHANISM, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 639-643
Authors:
JIMENEZ E
BOSCH F
LOPEZ A
COSTA J
COS R
BANOS JE
Citation: E. Jimenez et al., PATTERNS OF REGULAR DRUG-USE IN SPANISH CHILDBEARING WOMEN - CHANGES ELICITED BY PREGNANCY, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 645-651
Authors:
HENRICSON K
MELANDER E
MOLSTAD S
RANSTAM J
HANSON BS
RAMETSTEINER G
STENBERG P
MELANDER A
Citation: K. Henricson et al., INTRAURBAN VARIATION OF ANTIBIOTIC UTILIZATION IN CHILDREN - INFLUENCE OF SOCIOECONOMIC-FACTORS, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 653-657
Authors:
MAISON P
GUILLEMOT D
VAUZELLEKERVROEDAN F
BALKAU B
SERMET C
THIBULT N
ESCHWEGE E
Citation: P. Maison et al., TRENDS IN ASPIRIN, PARACETAMOL AND NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE IN CHILDREN BETWEEN 1981 AND 1992 IN FRANCE, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 659-664
Authors:
SPIGSET O
Citation: O. Spigset, ARE ADVERSE DRUG-REACTIONS ATTRIBUTED TO FLUVOXAMINE CAUSED BY CONCOMITANT INTAKE OF CAFFEINE, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 665-666
Authors:
SCHWARZ UI
KRAPPWEIS J
STOELBEN S
KIRCH W
Citation: Ui. Schwarz et al., DRUG INFORMATION-SERVICES - INITIAL EXPERIENCES IN DRESDEN, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 667-668
Authors:
SJOQVIST F
EICHELBAUM M
DAHLQVIST R
Citation: F. Sjoqvist et al., DENGLER,HANS,J - IN-MEMORIAM, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 495-495
Authors:
FRIDMAN K
ANDERSSON OK
WYSOCKI M
FRIBERG P
SUNZEL M
Citation: K. Fridman et al., ACUTE EFFECTS OF CANDESARTAN CILEXETIL (THE NEW ANGIOTENSIN-II ANTAGONIST) ON SYSTEMIC AND RENAL HEMODYNAMICS IN HYPERTENSIVE PATIENTS, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 497-501
Authors:
HEUBERGER W
BERARDI S
JACKY E
PEY P
KRAHENBUHL S
Citation: W. Heuberger et al., INCREASED URINARY-EXCRETION OF CARNITINE IN PATIENTS TREATED WITH CISPLATIN, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 503-508
Authors:
JONSSON E
FRIDBORG H
NYGREN P
LARSSON R
Citation: E. Jonsson et al., SYNERGISTIC INTERACTIONS OF COMBINATIONS OF TOPOTECAN WITH STANDARD DRUGS IN PRIMARY CULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 509-514
Authors:
MIADONNA A
MILAZZO N
SALMASO C
COTTINI M
LORINI M
TEDESCHI A
Citation: A. Miadonna et al., N-ACETYL-ASPARTYL-GLUTAMIC ACID INHIBITS CELLULAR RECRUITMENT AND MEDIATOR RELEASE DURING THE LATE ALLERGEN-INDUCED NASAL REACTION, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 515-520
Authors:
HUMMEL T
ROTHBAUER C
PAULI E
KOBAL G
Citation: T. Hummel et al., EFFECTS OF THE NASAL DECONGESTANT OXYMETAZOLINE ON HUMAN OLFACTORY AND INTRANASAL TRIGEMINAL FUNCTION IN ACUTE RHINITIS, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 521-528
Authors:
STOVER JF
STOCKER R
Citation: Jf. Stover et R. Stocker, BARBITURATE COMA MAY PROMOTE REVERSIBLE BONE-MARROW SUPPRESSION IN PATIENTS WITH SEVERE ISOLATED TRAUMATIC BRAIN INJURY, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 529-534
Authors:
LANGE S
FREITAG G
TRAMPISCH HJ
Citation: S. Lange et al., PRACTICAL EXPERIENCE WITH THE DESIGN AND ANALYSIS OF A 3-ARMED EQUIVALENCE STUDY, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 535-540
Authors:
SENGUPTA S
VELPANDIAN T
KABIR SR
GUPTA SK
Citation: S. Sengupta et al., ANALGESIC EFFICACY AND PHARMACOKINETICS OF TOPICAL NIMESULIDE GEL IN HEALTHY-HUMAN VOLUNTEERS - DOUBLE-BLIND COMPARISON WITH PIROXICAM, DICLOFENAC AND PLACEBO, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 541-547
Authors:
COHEN O
ZYLBERKATZ E
CARACO Y
GRANIT L
LEVY M
Citation: O. Cohen et al., CEREBROSPINAL-FLUID AND PLASMA-CONCENTRATIONS OF DIPYRONE METABOLITESAFTER A SINGLE ORAL DOSE OF DIPYRONE, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 549-553